Host immunity in the protective response to vaccination with heat-killed Burkholderia mallei

BMC Immunology

Volumn 9, Issue , 2008, Pages

  Whitlock, Gregory C ^a,b   Lukaszewski, Roman A ^c   Judy, Barbara M ^a   Paessler, Slobodan ^a   Torres, Alfredo G ^a   Estes, D Mark ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^c DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; BURKHOLDERIA MALLEI VACCINE; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; COMPLEMENT; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; BLOCKING ANTIBODY; INACTIVATED VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BURKHOLDERIA MALLEI; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSAGE FORM COMPARISON; FEMALE; HEAT; HOST RESISTANCE; INFECTION RESISTANCE; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; SURVIVAL RATE; VACCINATION; ACTIVE IMMUNIZATION; ANIMAL; BAGG ALBINO MOUSE; HORSE DISEASE; IMMUNOLOGY; METABOLISM; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, BLOCKING; B-LYMPHOCYTES; BACTERIAL VACCINES; BURKHOLDERIA MALLEI; GLANDERS; IMMUNITY, ACTIVE; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA; VACCINATION; VACCINES, INACTIVATED;

EID: 53549118017     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-9-55     Document Type: Article

References (21)

1. Neubauer H Sprague LD Zacharia R Tomaso H Al Dahouk S Wernery R Wernery U Scholz HC Serodiagnosis of Burkholderia mallei infections in horses: state-of-the-art and perspectives J Vet Med B Infect Dis Vet Public Health 2005, 52:201-5 16115091
2. Srinivasan A Kraus CN DeShazer D Becker PM Dick JD Spacek L Bartlett JG Byrne WR Thomas DL Glanders in a military research microbiologist N Engl J Med 2001, 345:256-8 10.1056/NEJM200107263450404 11474663
3. Sanford J Pseudomonas species (including melioidosis and glanders) New York Churchill Livingstone 4 1995
4. Amemiya K Bush GV DeShazer D Waag DM Nonviable Burkholderia mallei induces a mixed Th1- and Th2-like cytokine response in BALB/c mice Infect Immun 2002, 70:2319-25 127890 11953366 10.1128/ IAI.70.5.2319-2325.2002
5. Trevino SR Permenter AR England MJ Parthasarathy N Gibbs PH Waag DM Chanh TC Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge Infect Immun 2006, 74:1958-61 1418687 16495574 10.1128/IAI.74.3.1958-1961.2006
6. Amemiya K Meyers JL Trevino SR Chanh TC Norris SL Waag DM Interleukin-12 induces a Th1-like response to Burkholderia mallei and limited protection in BALB/c mice Vaccine 2006, 24:1413-20 10.1016/ j.vaccine.2005.09.021 16213631
7. Rowland CA Lertmemongkolchai G Bancroft A Haque A Lever MS Griffin KF Jackson MC Nelson M O'Garra A Grencis R et al.: Critical role of type 1 cytokines in controlling initial infection with Burkholderia mallei Infect Immun 2006, 74:5333-40 1594859 16926428 10.1128/IAI.02046-05
8. Santanirand P Harley VS Dance DA Drasar BS Bancroft GJ Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei Infect Immun 1999, 67:3593-600 116549 10377144
9. Haque A Easton A Smith D O'Garra A Van Rooijen N Lertmemongkolchai G Titball RW Bancroft GJ Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection J Infect Dis 2006, 193:370-9 10.1086/498983 16388484
10. Healey GD Elvin SJ Morton M Williamson ED Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection Infect Immun 2005, 73:5945-51 1231116 16113315 10.1128/ IAI.73.9.5945-5951.2005
11. Mittrucker HW Raupach B Kohler A Kaufmann SH Cutting edge: Role of B lymphocytes in protective immunity against Salmonella typhimurium infection J Immunol 2000, 164:1648-52 10657605
12. Jones SM Ellis JF Russell P Griffin KF Oyston PC Passive protection against Burkholderia pseudomallei infection in mice by monoclonal antibodies against capsular polysaccharide, lipopolysaccharide or proteins J Med Microbiol 2002, 51:1055-62 12466403
13. Reckseidler-Zenteno SL DeVinney R Woods DE The capsular polysaccharide of Burkholderia pseudomallei contributes to survival in serum by reducing complement factor C3b deposition Infect Immun 2005, 73:1106-15 547107 15664954 10.1128/IAI.73.2.1106-1115.2005
14. DeShazer D Waag DM Fritz DL Woods DE Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant Microb Pathog 2001, 30:253-69 10.1006/mpat.2000.0430 11373120
15. Whitlock GC Estes DM Torres AG Glanders: Off to the races with Burkholderia mallei FEMS Microbiol Lett 2007, 277:115-22 10.1111/ j.1574-6968.2007.00949.x 18031330
16. Whitlock GC Estes DM Young G Young B Torres AG Construction of a reporter system to study Burkholderia mallei type III secretion and identification of the BopA effector protein function in intracellular survival Trans R Soc Trop Med Hyg 2008
17. Test ST Mitsuyoshi JK Hu Y Depletion of complement has distinct effects on the primary and secondary antibody responses to a conjugate of pneumococcal serotype 14 capsular polysaccharide and a T-cell-dependent protein carrier Infect Immun 2005, 73:277-86 538989 15618164 10.1128/ IAI.73.1.277-286.2005
18. Fritz DL Vogel P Brown DR Deshazer D Waag DM Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei) Vet Pathol 2000, 37:626-36 10.1354/vp.37-6-626 11105952
19. Estes DM Teale JM In vivo effects of anticytokine antibodies on isotype restriction in Mesocestoides corti-infected BALB/c mice Infect Immun 1991, 59:836-42 258335 1997434
20. Coligan JE Kruisbeek AM Margulies DH Shevach EM Strober W Current Protocols in Immunology New York: John Wiley and Sons, Inc 1996
21. Lambert KC Curran EM Judy BM Milligan GN Lubahn DB Estes DM Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation J Immunol 2005, 175:5716-23 16237062